Prognostic implications of C-reactive protein and troponin following percutaneous coronary intervention

Jaroslav Hubacek1, Rashpal S Basran, Fiona M Shrive

  • 1Department of Cardiovascular Sciences and Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta.

Insights

Elevated C-reactive protein (CRP) and acute coronary syndrome predict troponin T (TnT) rise after PCI. However, this TnT rise does not indicate long-term adverse events following uncomplicated PCI.

Area of Science:

  • Cardiology
  • Biomarkers
  • Interventional Cardiology

Background:

  • C-reactive protein (CRP) is an inflammation marker implicated in atherosclerosis.
  • The link between CRP and troponin T (TnT) elevation post-percutaneous coronary intervention (PCI) is not well-defined.
  • Long-term outcomes of TnT increase after PCI require further investigation.

Purpose of the Study:

  • To investigate the association between CRP levels and TnT elevation following PCI.
  • To assess the long-term prognostic significance of TnT rise after PCI.

Main Methods:

  • 1208 patients undergoing successful non-emergent PCI were studied.
  • Baseline CRP and TnT levels were measured before and after PCI.
  • Two-year follow-up data were collected to evaluate long-term outcomes.

Main Results:

  • 20% of patients experienced a significant TnT rise post-PCI.
  • Predictors of TnT rise included acute coronary syndrome, no statin use, elevated CRP, and longer stent length.
  • Periprocedural TnT rise was not linked to adverse events at two-year follow-up.

Conclusions:

  • Myocardial necrosis (indicated by TnT rise) is common after PCI, especially in patients with recent myocardial infarction.
  • Statin therapy was associated with a blunted TnT response.
  • Uncomplicated PCI with periprocedural TnT rise did not result in long-term adverse sequelae.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...